Innovation Pharmaceuticals Inc (IPIX)

[slickWatts]

One option would be to develop a single medication combining caspofungin and brilacidin so that they acted together,” said Gustavo Henrique Goldman (https://bv.fapesp.br/en/pesquisador/480/gustavo-henrique-goldman), last author of the article and a professor at FCFRP-USP.

Clinical trials are needed to confirm the effects in humans. In partnership with Innovation Pharmaceuticals Inc. (IPI), the US-based company that owns the patent on brilacidin, the researchers are now looking for a Brazilian company interested in licensing the drug, conducting clinical trials, and marketing one of the combinations, if the trials are successful.

https://www.eurekalert.org/news-releases/995083